Creating Cancer Treatments for an Aging Population: Four Ways To Increase Cancer Clinical Trial Participation of Underrepresented Older Patients

Creating Cancer Treatments for an Aging Population: Four Ways To Increase Cancer Clinical Trial Participation of Underrepresented Older Patients

Older adults are projected to outnumber kids for the first time in US history by 2034. As our population ages, preparations must be made across industries, fields of study and governments to address its evolving needs, including in clinical trials that set the standards for efficacy and safety of new treatments, especially in cancer. Ageism … Read more

How “Lung Intelligence” is Accelerating New Therapies

How “Lung Intelligence” is Accelerating New Therapies

More than 500 million people on the planet have chronic lung disease — all eager for better therapies. Unfortunately, the wait for novel treatment is a long and expensive one — it takes 14 years and more than $1 billion, with a failure rate of 95%, to get a single drug from research labs to … Read more

How flipMD is Helping Physicians Create Hybrid Careers to Improve Healthcare

How flipMD is Helping Physicians Create Hybrid Careers to Improve Healthcare

In a webinar sponsored by flipMDfrom GoodRx, panelists discussed how the company is helping healthcare businesses optimize product development, marketing and go-to-market strategy, user adoption and more – all through collaboration with practicing physicians. Panelist Dr. Gregory Hanson, co-founder of flipMD, shared how he developed the idea for flipMD when he and his wife lived … Read more

Eisai Alzheimer’s Drug Data Show Slowing of Decline But Safety Questions Linger

Eisai Alzheimer’s Drug Data Show Slowing of Decline But Safety Questions Linger

Eisai now has the most detailed look yet at the clinical trial data for its Alzheimer’s disease drug lecanemab, with results showing reductions in telltale disease indicators and a slowing of clinical decline. But the results come amid recent reports of two patient deaths in the study, raising questions about whether the benefits from the … Read more

Does the Rumored Amwell/Talkspace Deal Make Sense? Experts Weigh In

Does the Rumored Amwell/Talkspace Deal Make Sense?  Experts Weigh In

Amid rumors that telemedicine company Amwell is exploring purchasing online therapy company Talkspace, industry experts seem somewhat torn on if the potential deal makes sense. What has been reported is that Amwell would acquire Talkspace for about $200 million at about $1.50 per share. It represents a steep drop from when the teletherapy company went … Read more

What Should Tech Companies Do to Navigate Privacy Concerns in the Post-Dobbs Era?

What Should Tech Companies Do to Navigate Privacy Concerns in the Post-Dobbs Era?

Patient privacy is evolving rapidly in the post-Dobbs era, according to healthcare and life science lawyers in a webinar hosted by the American Bar Association on Wednesday. “For now, a request from law enforcement personnel for protected health information is not valid unless it is pursuant to a process or as otherwise required by law,” … Read more

Google Partners with iCAD, Licenses Its Mammography AI Model for the First Time

Google Partners with iCAD, Licenses Its Mammography AI Model for the First Time

Medical device manufacturer iCAD is integrating Google Health‘s mammography AI technology into its suite of breast imaging AI products, the Nashua, NH-based company announced Monday. The two companies are entering into a development and commercialization agreement. In fact, the agreement marks Google’s first commercial partnership to deploy its breast imaging AI model into clinical practice. … Read more

To Fix Burnout, Providers Must Think Beyond Monetary Rewards

To Fix Burnout, Providers Must Think Beyond Monetary Rewards

Excessive burnout and workforce shortages are plaguing healthcare providers across the country, forcing some providers to close their doors. During a session on Monday at RSNA 2022 (the annual radiology and medical imaging conference in Chicago), half of the room of about 100 people raised their hands when asked if they had to close clinics … Read more

Medcity Pivot Podcast: A Conversation With COTA CEO Miruna Sasu About RWE

Medcity Pivot Podcast: A Conversation With COTA CEO Miruna Sasu About RWE

The importance of Real World Data and Real World Evidence is only growing as healthcare organizations recognize that they are strong tools with the power to improve patient outcomes. In the world of life sciences and drug development, the use of RWE is also slowly taking off. In this episode of MedCity’s Pivot Podcast, Miruna … Read more

Designing Health Sciences Education: Pivoting to the Future of Healthcare

Designing Health Sciences Education: Pivoting to the Future of Healthcare

While many will remember the Covid-19 pandemic as a source of disruption, it is likely that it will also be viewed as a catalyst for the transformation of medical education that had been brewing for the past decade. Educators across the country recognized that the physician workforce needed to embrace the enduring competencies of professionalism, … Read more